Jacob Chacko - Mar 6, 2024 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Christian Kuhlen, attorney-in-fact
Stock symbol
ORIC
Transactions as of
Mar 6, 2024
Transactions value $
-$648,380
Form type
4
Date filed
3/8/2024, 04:20 PM
Previous filing
Feb 8, 2024
Next filing
May 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale -$648K -40K -5.2% $16.21 729K Mar 6, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 28, 2022.
F2 Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $16.00 to $16.43 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.